Ruth Tupper

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Introduction. The risk of gastrointestinal (GI) bleeding with rivaroxaban has not been studied extensively. The aim of our study was to assess this risk in comparison to warfarin. Methods. We examined the medical records for patients who were started on rivaroxaban or warfarin from April 2011 to April 2013. Results. We identified 300 patients (147 on(More)
  • 1